Label-free impedance-based whole cell assay to study GPCR pharmacology
- 1 January 2019
- book chapter
- Published by Elsevier
- Vol. 149, 179-194
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensorBiochemical Pharmacology, 2018
- Label-free technology and patient cells: from early drug development to precision medicineDrug Discovery Today, 2017
- Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2Journal of Medicinal Chemistry, 2017
- Detection and Quantification of Allosteric Modulation of Endogenous M4 Muscarinic Acetylcholine Receptor Using Impedance-Based Label-Free Technology in a Neuronal Cell LineSLAS Discovery, 2015
- Combining label-free cell phenotypic profiling with computational approaches for novel drug discoveryExpert Opinion on Drug Discovery, 2015
- Using label-free screening technology to improve efficiency in drug discoveryExpert Opinion on Drug Discovery, 2012
- Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of DepressionJournal of Neurogenetics, 2011
- Label-Free Cell-Based Assays for GPCR ScreeningCombinatorial Chemistry & High Throughput Screening, 2008
- Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouseGenomics, 2006
- The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and FingerprintsMolecular Pharmacology, 2003